{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:15:51Z","timestamp":1789805751440,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02483-3","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:50:08Z","timestamp":1789804208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurexophilin 4 facilitates the malignant progression of kidney renal clear cell carcinoma by regulating PI3K\/AKT-mediated glycolysis"],"prefix":"10.1007","volume":"301","author":[{"given":"Xiaolei","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"2483_CR1","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.phrs.2019.104511","volume":"150","author":"AF Abdel-Wahab","year":"2019","unstructured":"Abdel-Wahab AF, Mahmoud W, Al-Harizy RM (2019) Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res 150:104511. https:\/\/doi.org\/10.1016\/j.phrs.2019.104511","journal-title":"Pharmacol Res"},{"key":"2483_CR2","doi-asserted-by":"publisher","first-page":"C890","DOI":"10.1152\/ajpcell.00322.2014","volume":"308","author":"O Abu Aboud","year":"2015","unstructured":"Abu Aboud O, Donohoe D, Bultman S, Fitch M, Riiff T, Hellerstein M, Weiss RH (2015) PPARalpha inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth. Am J Physiol Cell Physiol 308:C890\u2013898. https:\/\/doi.org\/10.1152\/ajpcell.00322.2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"2483_CR3","doi-asserted-by":"publisher","first-page":"116007","DOI":"10.1016\/j.envres.2023.116007","volume":"234","author":"AG Alkhathami","year":"2023","unstructured":"Alkhathami AG, Sahib AS, Al Fayi MS, Fadhil AA, Jawad MA, Shafik SA, Sultan SJ, Almulla AF, Shen M (2023) Glycolysis in human cancers: Emphasis circRNA\/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy. Environ Res 234:116007. https:\/\/doi.org\/10.1016\/j.envres.2023.116007","journal-title":"Environ Res"},{"key":"2483_CR4","doi-asserted-by":"publisher","unstructured":"Badoiu SC, Greabu M, Miricescu D et al (2023) PI3K\/AKT\/mTOR dysregulation and reprogramming metabolic pathways in renal cancer: crosstalk with the VHL\/HIF axis. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24098391","DOI":"10.3390\/ijms24098391"},{"key":"2483_CR5","unstructured":"Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L (2022) Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol 39"},{"key":"2483_CR6","doi-asserted-by":"publisher","unstructured":"Chelakkot C, Chelakkot VS, Shin Y, Song K (2023) Modulating glycolysis to improve cancer therapy. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24032606","DOI":"10.3390\/ijms24032606"},{"key":"2483_CR7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/s12967-025-06761-3","volume":"23","author":"X Chen","year":"2025","unstructured":"Chen X, Wang Q, Zhu Z, Peng Z, Huang K, Deng G, Jiang K, Chen K, Sun F (2025) TRIP13-induced NUSAP1 upregulation promotes CcRCC progression through EMT and PI3K\/AKT\/mTOR pathway. J Transl Med 23:890. https:\/\/doi.org\/10.1186\/s12967-025-06761-3","journal-title":"J Transl Med"},{"key":"2483_CR8","doi-asserted-by":"publisher","unstructured":"Eun JW, Jang JW, Yang HD et al (2022) Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; a panel of biomarkers for early diagnosis of hepatocellular carcinoma. J Clin Med 11. https:\/\/doi.org\/10.3390\/jcm11082128","DOI":"10.3390\/jcm11082128"},{"key":"2483_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3892\/etm.2023.12133","volume":"26","author":"Q Fan","year":"2023","unstructured":"Fan Q, He W, Shang Y (2023) Forkhead box protein K1\u2013regulated neurexophilin 4 promotes proliferation, metastasis and glycolysis in colorectal cancer. Exp Ther Med 26:434. https:\/\/doi.org\/10.3892\/etm.2023.12133","journal-title":"Exp Ther Med"},{"key":"2483_CR10","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P (2024) The PI3K\/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. Int J Biol Sci 20:3113\u20133125. https:\/\/doi.org\/10.7150\/ijbs.89942","journal-title":"Int J Biol Sci"},{"key":"2483_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41419-023-05779-z","volume":"14","author":"J Hao","year":"2023","unstructured":"Hao J, Chen Q, Feng Y et al (2023) Combination treatment with FAAH inhibitors\/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway. Cell Death Dis 14:247. https:\/\/doi.org\/10.1038\/s41419-023-05779-z","journal-title":"Cell Death Dis"},{"key":"2483_CR12","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V (2017) Renal cell carcinoma. Nat Rev Dis Primers 3:17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9","journal-title":"Nat Rev Dis Primers"},{"key":"2483_CR13","doi-asserted-by":"publisher","first-page":"116805","DOI":"10.1016\/j.biopha.2024.116805","volume":"175","author":"A Kowalewski","year":"2024","unstructured":"Kowalewski A, Borowczak J, Maniewski M, Gostomczyk K, Grzanka D, Szylberg L (2024) Targeting apoptosis in clear cell renal cell carcinoma. Biomed Pharmacother 175:116805. https:\/\/doi.org\/10.1016\/j.biopha.2024.116805","journal-title":"Biomed Pharmacother"},{"key":"2483_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4149\/neo_2025_250321N133","volume":"72","author":"S Liu","year":"2025","unstructured":"Liu S, Shen G, Zhou X, Wang G, Liu H, Cao Y, Sun L, Shu X, Ran Y (2025) High glycolysis phenotype influences malignant progression and poor prognosis of gastric cancer through the PI3K\/AKT pathway. Neoplasma 72:286\u2013299. https:\/\/doi.org\/10.4149\/neo_2025_250321N133","journal-title":"Neoplasma"},{"key":"2483_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/10668969241256111","volume":"33","author":"BG Nezami","year":"2025","unstructured":"Nezami BG, MacLennan GT (2025) Clear Cell Renal Cell Carcinoma: A Comprehensive Review of its Histopathology, Genetics, and Differential Diagnosis. Int J Surg Pathol 33:265\u2013280. https:\/\/doi.org\/10.1177\/10668969241256111","journal-title":"Int J Surg Pathol"},{"key":"2483_CR16","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.7150\/ijbs.109803","volume":"21","author":"Z Niu","year":"2025","unstructured":"Niu Z, He J, Wang S et al (2025) Targeting Glycolysis for Treatment of Breast Cancer Resistance: Current Progress and Future Prospects. Int J Biol Sci 21:2589\u20132605. https:\/\/doi.org\/10.7150\/ijbs.109803","journal-title":"Int J Biol Sci"},{"key":"2483_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10616-025-00869-6","volume":"78","author":"Q Qiao","year":"2026","unstructured":"Qiao Q, Guo L, Ma Z (2026) ETS1 facilitates the progression of OSCC and contributes to macrophage M2 polarization via regulating NXPH4. Cytotechnology 78:7. https:\/\/doi.org\/10.1007\/s10616-025-00869-6","journal-title":"Cytotechnology"},{"key":"2483_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY (2024) Renal Cell Carcinoma: A Review. JAMA 332:1001\u20131010. https:\/\/doi.org\/10.1001\/jama.2024.12848","journal-title":"JAMA"},{"key":"2483_CR19","doi-asserted-by":"publisher","unstructured":"Stolpa W, Strek-Cholewinska A, Mizia-Malarz A (2022) Clear cell renal cell carcinoma, diagnostic and therapeutic difficulties, case report and literature review. Med (Kaunas) 58. https:\/\/doi.org\/10.3390\/medicina58101329","DOI":"10.3390\/medicina58101329"},{"key":"2483_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.21037\/jgo-23-956","volume":"15","author":"Z Sun","year":"2024","unstructured":"Sun Z, Wang H, Xu Y, Liu Y, Wang L, Zhou R, Zhou R, Ma W, Zhang T (2024) High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma. J Gastrointest Oncol 15:641\u2013667. https:\/\/doi.org\/10.21037\/jgo-23-956","journal-title":"J Gastrointest Oncol"},{"key":"2483_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41420-026-02944-z","volume":"12","author":"X Sun","year":"2026","unstructured":"Sun X, Zhang Y, Zhang W, Jin L, Xin S (2026) Targeting NXPH4\/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer. Cell Death Discov 12:91. https:\/\/doi.org\/10.1038\/s41420-026-02944-z","journal-title":"Cell Death Discov"},{"key":"2483_CR23","doi-asserted-by":"publisher","unstructured":"Waldbillig F, Bormann F, Neuberger M, Ellinger J, Erben P, Kriegmair MC, Michel MS, Nuhn P, Nientiedt M (2023) An m6A-driven prognostic marker panel for renal cell carcinoma based on the first transcriptome-wide m6A-seq. Diagnostics (Basel) 13. https:\/\/doi.org\/10.3390\/diagnostics13050823","DOI":"10.3390\/diagnostics13050823"},{"key":"2483_CR24","doi-asserted-by":"publisher","unstructured":"Wang D, Zhang P, Liu Z, Xing Y, Xiao Y (2022) NXPH4 promotes gemcitabine resistance in bladder cancer by enhancing reactive oxygen species and glycolysis activation through modulating NDUFA4L2. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14153782","DOI":"10.3390\/cancers14153782"},{"key":"2483_CR25","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.62347\/ZLOS1416","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Li Z, Wang L, Ren Y, Li D (2025) FOXK1-induced upregulation of NXPH4 predicts poor prognosis and promotes hepatocellular carcinoma progression via PI3K\/Akt pathway. Am J Cancer Res 15:3164\u20133187. https:\/\/doi.org\/10.62347\/ZLOS1416","journal-title":"Am J Cancer Res"},{"key":"2483_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s12967-022-03805-w","volume":"20","author":"J Wu","year":"2022","unstructured":"Wu J, Miao C, Wang Y, Wang S, Wang Z, Liu Y, Wang X, Wang Z (2022) SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner. J Transl Med 20:603. https:\/\/doi.org\/10.1186\/s12967-022-03805-w","journal-title":"J Transl Med"},{"key":"2483_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41419-023-06207-y","volume":"14","author":"C Wu","year":"2023","unstructured":"Wu C, Zheng C, Chen S, He Z, Hua H, Sun C, Yu C (2023) FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis. Cell Death Dis 14:699. https:\/\/doi.org\/10.1038\/s41419-023-06207-y","journal-title":"Cell Death Dis"},{"key":"2483_CR28","doi-asserted-by":"publisher","first-page":"130801","DOI":"10.1016\/j.bbagen.2025.130801","volume":"1869","author":"Z Xiao","year":"2025","unstructured":"Xiao Z, Wang Y, Pan D, Liu X, Gan J, Huang L, Feng Y (2025) USP3 promotes clear cell renal cell carcinoma progression by stabilizing MYC and enhancing glycolysis. Biochim Biophys Acta Gen Subj 1869:130801. https:\/\/doi.org\/10.1016\/j.bbagen.2025.130801","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2483_CR29","doi-asserted-by":"publisher","first-page":"2304161","DOI":"10.1080\/15384047.2024.2304161","volume":"25","author":"F Yan","year":"2024","unstructured":"Yan F, Teng Y, Li X, Zhong Y, Li C, Yan F, He X (2024) Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer Biol Ther 25:2304161. https:\/\/doi.org\/10.1080\/15384047.2024.2304161","journal-title":"Cancer Biol Ther"},{"key":"2483_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s11658-024-00630-5","volume":"29","author":"L Yang","year":"2024","unstructured":"Yang L, Shi J, Zhong M et al (2024) NXPH4 mediated by m(5)C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation. Cell Mol Biol Lett 29:111. https:\/\/doi.org\/10.1186\/s11658-024-00630-5","journal-title":"Cell Mol Biol Lett"},{"key":"2483_CR30","doi-asserted-by":"publisher","unstructured":"Yang DD, Xue ZK, Jia SQ et al (2026) Bioinformatic analysis and cellular functional assays uncover the role of NXPH4 in breast cancer. Discov Oncol 17. https:\/\/doi.org\/10.1007\/s12672-026-04519-x","DOI":"10.1007\/s12672-026-04519-x"},{"key":"2483_CR32","doi-asserted-by":"publisher","unstructured":"Zhang Z, Wang P, Chen S et al (2024) NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression. Aging (Albany NY) 16:5866-5886 https:\/\/doi.org\/10.18632\/aging.205648","DOI":"10.18632\/aging.205648"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02483-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:50:09Z","timestamp":1789804209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02483-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2483"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02483-3","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no competing interest exists.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"198"}}